Research & Development



  司馬遷一直都很忙,即便是雲瑯也不知道他到底在忙些什麼,大雪初晴的時候,面容蠟黃的司馬遷第一次走出屋子,享受難得一見的陽光。   這樣的人在大漢絕對是頂尖的風雲老奸賊。久久视频这里只精品99热   劉徹大笑道︰“大不敬啊!”亚洲香蕉视频在线播放   如此半個時辰之後,蛋頭結束了問話。   霍去病見雲瑯不說話,就問道︰“舅母怎麼說?”青青草av   甦稚沒有學過莫爾斯電碼,天知道她的鼓點代表什麼含義。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo